PL356784A1 - Substancja do zastosowania w leczeniu łuszczycy - Google Patents

Substancja do zastosowania w leczeniu łuszczycy

Info

Publication number: PL356784A1
Authority: PL; Poland
Prior art keywords: psoriasis; substance; treatment
Prior art date: 2000-01-12

Application number

PL01356784A

Other languages

English (en)

Other versions

PL212010B1 (pl

Inventor

Napoli Guido Di

Original Assignee

Laboratoire Medidom S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-12

Filing date

2001-01-08

Publication date

2004-07-12

2001-01-08 Application filed by Laboratoire Medidom S.A. filed Critical Laboratoire Medidom S.A.

2004-07-12 Publication of PL356784A1 publication Critical patent/PL356784A1/pl

2012-07-31 Publication of PL212010B1 publication Critical patent/PL212010B1/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL356784A 2000-01-12 2001-01-08 Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej PL212010B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH532000		2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en)	2000-01-12	2001-01-08	Substances for use in treating psoriasis

Publications (2)

Publication Number	Publication Date
PL356784A1 true PL356784A1 (pl)	2004-07-12
PL212010B1 PL212010B1 (pl)	2012-07-31

Family

ID=4291590

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL356784A PL212010B1 (pl)	2000-01-12	2001-01-08	Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej

Country Status (22)

Country	Link
US (2)	US6844365B2 (pl)
EP (1)	EP1248608B1 (pl)
JP (1)	JP4912554B2 (pl)
CN (1)	CN1187045C (pl)
AR (1)	AR026801A1 (pl)
AT (1)	ATE254913T1 (pl)
AU (1)	AU776324B2 (pl)
BR (2)	BRPI0107493B8 (pl)
CA (1)	CA2396111C (pl)
CZ (1)	CZ301129B6 (pl)
DE (1)	DE60101309T2 (pl)
DK (1)	DK1248608T3 (pl)
ES (1)	ES2210120T3 (pl)
IL (2)	IL150390A0 (pl)
MX (1)	MXPA02006610A (pl)
PL (1)	PL212010B1 (pl)
PT (1)	PT1248608E (pl)
RU (1)	RU2266740C2 (pl)
SK (1)	SK286589B6 (pl)
TR (1)	TR200400228T4 (pl)
WO (1)	WO2001051044A2 (pl)
ZA (1)	ZA200205148B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020128317A1 (en) *	2001-01-23	2002-09-12	Laboratories Negma	Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) *	2002-12-30	2007-06-20	北京大学第一医院	大黄酸在抑制血管生成中的应用
BRPI0610058A2 (pt)	2005-05-16	2010-05-25	Abbott Biotech Ltd	uso de inibidor de tnf para tratamento da poliartrite erosiva
US9624295B2 (en) *	2006-04-10	2017-04-18	Abbvie Biotechnology Ltd.	Uses and compositions for treatment of psoriatic arthritis
US20080085912A1 (en) *	2006-10-06	2008-04-10	Unitech Pharmaceuticals, Inc.	Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) *	2007-11-16	2009-05-20	Laboratoire Medidom S.A.	Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) *	2008-04-30	2009-11-05	Wockhardt Research Centre	Topical compositions of rhein or diacerein
CN101537002B (zh) *	2009-04-24	2012-02-29	安士制药（中山）有限公司	具有优良溶出性能的双醋瑞因组合物及其制备和用途
MX2012011517A (es) *	2010-04-08	2012-11-29	Twi Biotechnology Inc	El uso de diacereina como una terapia adyuvante para diabetes.
WO2017123672A1 (en) *	2016-01-12	2017-07-20	Lawrence Chan	Combination treatment for inflammatory diseases
CN106236729A (zh) *	2016-07-31	2016-12-21	合肥远志医药科技开发有限公司	一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) *	2017-01-02	2017-05-24	佛山市腾瑞医药科技有限公司	一种微孔膜控释包衣双醋瑞因微丸及其制备方法
EP3570835B1 (en) *	2017-01-19	2023-08-09	TWI Biotechnology, Inc.	Diacerein for preventing or treating immunoinflammatory dermal disorders
CN106667954A (zh) *	2017-02-14	2017-05-17	佛山市腾瑞医药科技有限公司	一种双醋瑞因软胶囊制剂及其制备工艺
CN106619555A (zh) *	2017-02-14	2017-05-10	佛山市腾瑞医药科技有限公司	一种双醋瑞因速释微丸制剂、制备方法
CN106727360A (zh) *	2017-02-16	2017-05-31	佛山市腾瑞医药科技有限公司	一种双醋瑞因固体分散体制剂及其制备方法
CA3094295A1 (en) *	2018-03-29	2019-10-03	S.I.S. Shulov Innovative Science Ltd.	Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) *	2019-07-15	2021-01-21	R.P. Scherer Technologies, Llc	Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) *	2021-02-22	2021-05-07	北京市中医研究所	大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA761627B (en)	1976-03-16	1978-01-25	C Friedmann	Improvements in or relating to the treatment of arthritis
IT1197316B (it) *	1986-10-01	1988-11-30	Proter Spa	Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it)	1993-07-30	1996-10-02	Medidom Lab	Procedimento per la preparazione della diacereina
IT1282381B1 (it)	1996-04-29	1998-03-20	Trans Bussan S A	Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it)	1996-07-31	1998-04-30	Medidom Lab	Procedimento per la preparazione di derivati della reina
IT1283772B1 (it)	1996-07-31	1998-04-30	Medidom Lab	Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) *	1996-10-15	2008-02-20	正規小菅	津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) *	1996-10-18	2007-12-05	正規小菅	津液改善用皮膚外用剤
JPH10129556A (ja)	1996-10-28	1998-05-19	Fumiaki Mori	盗難防止自転車
FR2757397B1 (fr) *	1996-12-23	1999-03-05	Mazal Pharma	Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it)	1997-12-30	1999-08-03	Medidom Lab	Procedimento per la preparazione di reina e suoi diacilderivati

2001
- 2001-01-05 AR ARP010100050A patent/AR026801A1/es unknown
- 2001-01-08 CA CA002396111A patent/CA2396111C/en not_active Expired - Lifetime
- 2001-01-08 TR TR2004/00228T patent/TR200400228T4/xx unknown
- 2001-01-08 DK DK01900029T patent/DK1248608T3/da active
- 2001-01-08 CN CNB018036953A patent/CN1187045C/zh not_active Expired - Lifetime
- 2001-01-08 SK SK991-2002A patent/SK286589B6/sk not_active IP Right Cessation
- 2001-01-08 ES ES01900029T patent/ES2210120T3/es not_active Expired - Lifetime
- 2001-01-08 IL IL15039001A patent/IL150390A0/xx active IP Right Grant
- 2001-01-08 PL PL356784A patent/PL212010B1/pl unknown
- 2001-01-08 PT PT01900029T patent/PT1248608E/pt unknown
- 2001-01-08 MX MXPA02006610A patent/MXPA02006610A/es active IP Right Grant
- 2001-01-08 AU AU22132/01A patent/AU776324B2/en not_active Expired
- 2001-01-08 DE DE60101309T patent/DE60101309T2/de not_active Expired - Lifetime
- 2001-01-08 WO PCT/IB2001/000005 patent/WO2001051044A2/en not_active Ceased
- 2001-01-08 EP EP01900029A patent/EP1248608B1/en not_active Expired - Lifetime
- 2001-01-08 JP JP2001551468A patent/JP4912554B2/ja not_active Expired - Lifetime
- 2001-01-08 BR BRPI0107493A patent/BRPI0107493B8/pt unknown
- 2001-01-08 AT AT01900029T patent/ATE254913T1/de active
- 2001-01-08 RU RU2002121546/15A patent/RU2266740C2/ru active
- 2001-01-08 CZ CZ20022382A patent/CZ301129B6/cs not_active IP Right Cessation
- 2001-01-08 BR BR0107493-8A patent/BR0107493A/pt not_active IP Right Cessation
- 2001-03-02 US US09/798,355 patent/US6844365B2/en not_active Expired - Lifetime
2002
- 2002-06-25 IL IL150390A patent/IL150390A/en unknown
- 2002-06-26 ZA ZA200205148A patent/ZA200205148B/en unknown
2004
- 2004-07-28 US US10/900,740 patent/US20050004045A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2396111A1 (en)	2001-07-19
EP1248608A2 (en)	2002-10-16
BR0107493A (pt)	2002-10-08
MXPA02006610A (es)	2004-09-10
JP2003519653A (ja)	2003-06-24
BRPI0107493B8 (pt)	2021-05-25
CA2396111C (en)	2008-12-02
AU776324B2 (en)	2004-09-02
US20050004045A1 (en)	2005-01-06
CN1187045C (zh)	2005-02-02
JP4912554B2 (ja)	2012-04-11
US20020143057A1 (en)	2002-10-03
AR026801A1 (es)	2003-02-26
IL150390A (en)	2007-07-24
PL212010B1 (pl)	2012-07-31
CZ20022382A3 (cs)	2002-11-13
BRPI0107493B1 (pt)	2019-04-16
ZA200205148B (en)	2003-06-26
CZ301129B6 (cs)	2009-11-11
PT1248608E (pt)	2004-04-30
ATE254913T1 (de)	2003-12-15
TR200400228T4 (tr)	2004-02-23
US6844365B2 (en)	2005-01-18
DE60101309T2 (de)	2004-09-16
WO2001051044A3 (en)	2002-03-28
ES2210120T3 (es)	2004-07-01
EP1248608B1 (en)	2003-11-26
DK1248608T3 (da)	2004-04-05
AU2213201A (en)	2001-07-24
WO2001051044A2 (en)	2001-07-19
SK9912002A3 (en)	2003-02-04
CN1395484A (zh)	2003-02-05
RU2266740C2 (ru)	2005-12-27
SK286589B6 (sk)	2009-01-07
DE60101309D1 (de)	2004-01-08
IL150390A0 (en)	2002-12-01

Publication	Publication Date	Title
EE05507B1 (et)	2012-02-15	Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
EE200200461A (et)	2003-12-15	Pteridiiniühendid psoriaasi raviks
PL356784A1 (pl)	2004-07-12	Substancja do zastosowania w leczeniu łuszczycy
EE05073B1 (et)	2008-10-15	Retigabiin kasutamiseks neuropaatilise valu ravis
EE200100480A (et)	2002-12-16	Ksenoon kasutamiseks närvimürgistuste ravis
EE05481B1 (et)	2011-10-17	Kinasoliini derivaadid kasvajate raviks
FI20020071A7 (fi)	2002-03-13	Applikaattori kõytettõvõksi refleksoterapiassa
EE200200571A (et)	2004-04-15	Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
FI20020072A7 (fi)	2002-03-13	Applikaattori kõytettõvõksi refleksoterapiassa
NO20032122L (no)	2003-07-01	Forbedret behandling
NO20041214L (no)	2004-06-24	Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
NO20023482D0 (no)	2002-07-22	Fremgangsmåte for behandling av stoffmisbruk
DE60223576D1 (de)	2007-12-27	Hautbehandlungszusammensetzung
IS6966A (is)	2003-09-24	Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EE200200511A (et)	2004-02-16	Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
EE200200577A (et)	2004-06-15	Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
DE60222664D1 (de)	2007-11-08	Hautbehandlungsmittel
EE200200479A (et)	2003-12-15	Eksemestaani kasutamine rinnavähi ravis
NO20024236D0 (no)	2002-09-05	Behandling av psoriasis
DE60023003D1 (de)	2005-11-10	Haarbehandlungsmittel
ID30458A (id)	2001-12-06	Osanetan dalam pengobatan gangguan jiwa
NO20010569D0 (no)	2001-02-02	Proteaseinhibitorer for anvendelse ved behandling av psoriasis
IS6660A (is)	2002-12-19	Ný bispídínefnasambönd og notkun þeirra í meðhöndlun á hjartsláttarglöpum